Scholars@Duke publication: A Novel Cas9 System with Robust Genome and Epigenome Editing in Human Cells

A Novel Cas9 System with Robust Genome and Epigenome Editing in Human Cells

Publication , Conference

Butterfield, G; Rohm, D; Roberts, A; Nethery, M; Rizzo, A; Barrangou, R; Gersbach, C

Published in: MOLECULAR THERAPY

2022

MOLECULAR THERAPY

1525-0024

1525-0016

2022

271 / 272

APA

Chicago

ICMJE

MLA

NLM

Butterfield, G., Rohm, D., Roberts, A., Nethery, M., Rizzo, A., Barrangou, R., & Gersbach, C. (2022). A Novel Cas9 System with Robust Genome and Epigenome Editing in Human Cells. In MOLECULAR THERAPY (Vol. 30, pp. 271–272).

Butterfield, Gabriel, Dahlia Rohm, Avery Roberts, Matthew Nethery, Anthony Rizzo, Rodolphe Barrangou, and Charles Gersbach. “A Novel Cas9 System with Robust Genome and Epigenome Editing in Human Cells.” In MOLECULAR THERAPY, 30:271–72, 2022.

Butterfield G, Rohm D, Roberts A, Nethery M, Rizzo A, Barrangou R, et al. A Novel Cas9 System with Robust Genome and Epigenome Editing in Human Cells. In: MOLECULAR THERAPY. 2022. p. 271–2.

Butterfield, Gabriel, et al. “A Novel Cas9 System with Robust Genome and Epigenome Editing in Human Cells.” MOLECULAR THERAPY, vol. 30, no. 4, 2022, pp. 271–72.

Butterfield G, Rohm D, Roberts A, Nethery M, Rizzo A, Barrangou R, Gersbach C. A Novel Cas9 System with Robust Genome and Epigenome Editing in Human Cells. MOLECULAR THERAPY. 2022. p. 271–272.

MOLECULAR THERAPY

1525-0024

1525-0016

2022

271 / 272